Related Experiment Video

Updated: May 14, 2026

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

[Molecular pathology of the lungs. New perspectives by next generation sequencing]

C Vollbrecht1, K König, L Heukamp

  • 1Institut für Pathologie, Universitätsklinik zu Köln, Kerpener Str. 62, 50924, Köln, Deutschland.

Der Pathologe
|February 8, 2013
PubMed

Insights

Next-generation sequencing (NGS) offers a powerful tool for analyzing lung cancer mutations. This technology enables sensitive detection of low-frequency variants, crucial for understanding therapy response.

Area of Science:

  • Oncology
  • Molecular Pathology
  • Genetics

Background:

  • Lung cancer is a prevalent malignancy globally.
  • Mutations in signal transducer genes frequently impact lung cancer therapy response.
  • Efficient molecular pathology approaches are essential for personalized treatment.

Purpose of the Study:

  • To highlight the utility of next-generation sequencing (NGS) for comprehensive mutation analysis in lung cancer.
  • To emphasize the advantages of NGS in detecting low-frequency variants relevant to therapy response.

Main Methods:

  • Utilizing next-generation sequencing (NGS) platforms, including 454 pyrosequencing, sequencing by synthesis, and semiconductor sequencing.
  • Performing parallel sequencing of multiple target genes for comprehensive mutation profiling.
  • Applying the "one molecule, one clone, one read" principle for accurate variant detection.

Main Results:

  • NGS provides high-capacity, ultra-deep sequence analysis for tumor DNA.
  • NGS enables precise determination of allele frequencies and mutation rates.
  • NGS facilitates highly sensitive detection of low-frequency genetic variants.

Conclusions:

  • Next-generation sequencing (NGS) represents a significant advancement in molecular pathology for lung cancer.
  • NGS facilitates comprehensive genomic profiling, aiding in the identification of actionable mutations.
  • The sensitivity of NGS is critical for detecting variants that influence therapeutic strategies and patient outcomes.

More Related Videos

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Related Concept Videos

Next-generation Sequencing03:00

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Modern Molecular Taxonomy01:29

Modern Molecular Taxonomy

Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
RNA-seq03:21

RNA-seq

RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases. 
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while microarray-based...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Genomics02:02

Genomics

Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...